Bioequivalence and Bioavailability Forum 13:08 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

MaggieSantos
Junior

Portugal,
2018-07-03 18:41

Posting: # 19015
Views: 394
 

 Topical Drugs- IVRT [Regulatives / Guidelines]

Hello,

Regarding the new draft guidance on acyclovir ointment I have performed an IVRT test to compare the test and reference formulations. I used a Hanson system similar to the ones used for acyclovir creams.

During the validation of the test system, I applied the described parameters on draft guidance for acyclovir cream, namely, IVRT Discrimination Sensitivity, Specificity and Selectivity.

When comparing the lower (2.5%) and upper (7.5%) release rates to the 5% acyclovir ointment (PEG basis), the release rates were nor discriminatory.

As anyone performed this test, what results were obtained and what is the suggested reason for no discriminatory results. What is the impact?:confused:

Kind Regards

MeggieSantos
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
18,883 posts in 4,027 threads, 1,271 registered users;
online 13 (0 registered, 13 guests [including 7 identified bots]).

Those who make no mistakes are making the biggest mistakes of all –
they are attempting nothing new.    Anthony de Mello

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed